We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

106 hedge funds and large institutions have $39.9M invested in Acorda Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 37 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 37

12% less funds holding

Funds holding: 121 → 106 (-15)

52% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 25

62% less capital invested

Capital invested by funds: $106M → $39.9M (-$65.8M)

98% less call options, than puts

Call options by funds: $79K | Put options by funds: $3.77M

Holders
106
Holders Change
-15
Holders Change %
-12.4%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
33
Reduced
37
Closed
25
Calls
$79K
Puts
$3.77M
Net Calls
-$3.69M
Net Calls Change
-$3.72M

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.08M
2
Invesco
Invesco
Georgia
+$921K
3
JP Morgan Chase
JP Morgan Chase
New York
+$536K
4
GCP
GSA Capital Partners
United Kingdom
+$411K
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$296K

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.09M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.94M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.76M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1M
5
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$857K
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
126
Walleye Trading
New York
– -$6K -25 Closed
ClearBridge Investments
127
ClearBridge Investments
New York
– -$1K -4 Closed
PNC Financial Services Group
128
PNC Financial Services Group
Pennsylvania
– -$197 -1 -33%
2 3 4 5
6

ACOR Hedge Fund Activity: Q1 2020 in Review

106 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2020, worth a combined $39.9M — down 62% from $106M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ACOR and 12 opened new positions — a net loss of 13 holders — while 37 trimmed existing stakes and 33 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.08M. The largest seller was Point72 Asset Management, cutting an estimated $5.09M.

  • 106 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2020, down from 121 in Q4 2019.
  • Funds reported $39.9M of Acorda Therapeutics stock for Q1 2020, down 62% quarter-over-quarter.
  • 12 funds opened new Acorda Therapeutics positions in Q1 2020 and 25 closed out, a net change of -13 holders.
  • The largest Acorda Therapeutics buyer in Q1 2020 was Susquehanna International Group, an estimated $1.08M added.
  • The largest Acorda Therapeutics seller in Q1 2020 was Point72 Asset Management, an estimated $5.09M sold.

Based on aggregated 13F filings for Q1 2020.